Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy.
about
Recent advances in the field of anti-cancer immunotherapyDevelopment of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivoADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.Clinical implications of compounds designed to inhibit ECM-modifying metalloproteinases.Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.Molecular basis for the mechanism of action of an anti-TACE antibody.Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm.Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.Considerations on inhibition approaches for proinflammatory functions of ADAM proteases.Renal ADAM10 and 17: Their Physiological and Medical Meanings
P2860
Q26775602-77765011-B775-4271-8C99-944DDC965CEBQ37086127-82F1118D-E0E1-406A-9562-B4B9CA523B17Q38283936-23C1CF10-34F6-450E-86B9-8C1D9180BA24Q38430546-8102715B-5720-41D5-A71C-A777A984CB68Q39536410-B7B87163-E147-444D-B404-98E7259EE2E2Q42056348-AFE95836-186F-4FDD-A103-82996484CA98Q46131992-B7F7AF29-634F-405F-8056-8168C7C051D7Q46450905-6DF31B4F-439E-4D91-9CD8-752DE3D64D9AQ50495797-2AF6B4D1-4E98-4C8F-8484-93348DDFB6E1Q59136491-EA506683-0E07-4D8F-AAC9-B633D8CEE83A
P2860
Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development of a 'mouse and hu ...... M17) for cancer immunotherapy.
@ast
Development of a 'mouse and hu ...... M17) for cancer immunotherapy.
@en
type
label
Development of a 'mouse and hu ...... M17) for cancer immunotherapy.
@ast
Development of a 'mouse and hu ...... M17) for cancer immunotherapy.
@en
prefLabel
Development of a 'mouse and hu ...... M17) for cancer immunotherapy.
@ast
Development of a 'mouse and hu ...... M17) for cancer immunotherapy.
@en
P2093
P2860
P356
P1476
Development of a 'mouse and hu ...... AM17) for cancer immunotherapy
@en
P2093
Gillian Murphy
Hang Fai Kwok
John McCafferty
Kenneth A Botkjaer
Yanchao Huang
P2860
P304
P356
10.1093/PROTEIN/GZU010
P577
2014-04-24T00:00:00Z